EP3355877A4 - Composition pour réduire la fréquence de la miction, procédé de fabrication et d'utilisation de celle-ci - Google Patents

Composition pour réduire la fréquence de la miction, procédé de fabrication et d'utilisation de celle-ci Download PDF

Info

Publication number
EP3355877A4
EP3355877A4 EP16852276.1A EP16852276A EP3355877A4 EP 3355877 A4 EP3355877 A4 EP 3355877A4 EP 16852276 A EP16852276 A EP 16852276A EP 3355877 A4 EP3355877 A4 EP 3355877A4
Authority
EP
European Patent Office
Prior art keywords
miction
frequency
reducing
manufacturing
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16852276.1A
Other languages
German (de)
English (en)
Other versions
EP3355877A1 (fr
Inventor
David A. Dill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellesley Pharmaceuticals LLC
Original Assignee
Wellesley Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/870,676 external-priority patent/US10596127B2/en
Application filed by Wellesley Pharmaceuticals LLC filed Critical Wellesley Pharmaceuticals LLC
Publication of EP3355877A1 publication Critical patent/EP3355877A1/fr
Publication of EP3355877A4 publication Critical patent/EP3355877A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/612Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12Antidiuretics, e.g. drugs for diabetes insipidus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP16852276.1A 2015-09-30 2016-08-29 Composition pour réduire la fréquence de la miction, procédé de fabrication et d'utilisation de celle-ci Withdrawn EP3355877A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/870,676 US10596127B2 (en) 2013-03-14 2015-09-30 Composition for reducing the frequency of urination, method of making and use thereof
PCT/US2016/049246 WO2017058436A1 (fr) 2015-09-30 2016-08-29 Composition pour réduire la fréquence de la miction, procédé de fabrication et d'utilisation de celle-ci

Publications (2)

Publication Number Publication Date
EP3355877A1 EP3355877A1 (fr) 2018-08-08
EP3355877A4 true EP3355877A4 (fr) 2019-05-15

Family

ID=58424324

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16852276.1A Withdrawn EP3355877A4 (fr) 2015-09-30 2016-08-29 Composition pour réduire la fréquence de la miction, procédé de fabrication et d'utilisation de celle-ci

Country Status (7)

Country Link
EP (1) EP3355877A4 (fr)
JP (1) JP2018529710A (fr)
KR (1) KR20180066113A (fr)
CN (1) CN108430465A (fr)
AU (1) AU2016331879A1 (fr)
SG (1) SG11201805527QA (fr)
WO (1) WO2017058436A1 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9119878B2 (en) * 2010-07-08 2015-09-01 Wellesley Pharmaceuticals, Llc Extended-release formulation for reducing the frequency of urination and method of use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395626A (en) * 1994-03-23 1995-03-07 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
WO1999059552A1 (fr) * 1998-05-15 1999-11-25 Chugai Seiyaku Kabushiki Kaisha Preparations a liberation controlee
US20030194429A1 (en) * 2002-04-10 2003-10-16 Miller Frederick H. Multi-phase, multi-compartment capsular delivery apparatus for therapeutic compositions and methods for using same
MXPA04010408A (es) * 2002-04-24 2005-02-17 Boehringer Ingelheim Pharma Combinacion farmaceutica para el tratamiento de hiperplasia prostatica benigna o para la prevencion a largo plazo de la retencion urinaria aguda.
US20080095843A1 (en) * 2006-07-11 2008-04-24 Nutalapati Siva R K Controlled-release formulations
TWI609702B (zh) * 2006-11-09 2018-01-01 歐瑞根治療有限公司 層狀醫藥調配物
CN107569690A (zh) * 2012-01-04 2018-01-12 韦尔斯利医药有限公司 用于缓解尿频的延长释放制剂及其使用方法
MY173582A (en) * 2012-01-04 2020-02-04 Wellesley Pharmaceuticals Llc Extended-release formulation for reducing the frequency of urination and method of use thereof
CN103191430A (zh) * 2012-01-04 2013-07-10 韦尔斯利医药有限公司 用于缓解尿频的缓释制剂及其使用方法
CN107157991A (zh) * 2012-03-19 2017-09-15 韦尔斯利医药有限公司 用于缓解尿频的延长释放制剂及其使用方法
CN107335057A (zh) * 2012-07-27 2017-11-10 韦尔斯利医药有限公司 用于缓解尿频的药物制剂及其使用方法
TW201422254A (zh) * 2012-11-21 2014-06-16 Ferring Bv 用於速釋及延釋的組成物
BR102013020508B1 (pt) * 2013-08-12 2021-01-12 Ems S/A. Forma de dosagem que compreende um inibidor de esteroide 5-alfa-redutase e um bloqueador alfa, processo para a preparaçãode uma forma de dosagem e uso da forma de dosagem

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9119878B2 (en) * 2010-07-08 2015-09-01 Wellesley Pharmaceuticals, Llc Extended-release formulation for reducing the frequency of urination and method of use thereof

Also Published As

Publication number Publication date
CN108430465A (zh) 2018-08-21
JP2018529710A (ja) 2018-10-11
WO2017058436A1 (fr) 2017-04-06
EP3355877A1 (fr) 2018-08-08
SG11201805527QA (en) 2018-07-30
KR20180066113A (ko) 2018-06-18
AU2016331879A1 (en) 2018-05-17

Similar Documents

Publication Publication Date Title
EP3402815A4 (fr) Utilisation de mutants endo-s2 comme glycosynthases, procédé de fabrication et d'utilisation pour la glycoingénierie de glycoprotéines
EP3460021A4 (fr) Agent d'hydrofugation, et procédé de fabrication de celui-ci
MA43802A (fr) Matières cellulosiques et procédés de fabrication et d'utilisation de celles-ci
EP3395715A4 (fr) Récipient d'aliment et procédé de fabrication de celui-ci
EP3386550A4 (fr) Procédés et compositions pour la fabrication et l'utilisation d'acides nucléiques de guidage
EP3540001A4 (fr) Résine hautement absorbante et procédé pour sa production
EP2865647A4 (fr) Matière active d'anode et procédé pour la fabrication de celle-ci
EP3467135A4 (fr) Tôle d'acier mince, et procédé de fabrication de celle-ci
EP3378897A4 (fr) Composition de résine époxy, procédé pour sa production et utilisation de la composition
EP3425016A4 (fr) Composition pour polissage, et procédé de polissage mettant en ouvre celle-ci
MA46791A (fr) Composés et procédés pour réduire l'expression d'atxn3
EP3581618C0 (fr) Composition de caoutchouc, et procédé de fabrication de celle-ci
EP3455895A4 (fr) Compositions et procédés pour la fabrication d'électrode
MA42055A (fr) Composés antimicrobiens et procédés de fabrication et d'utilisation de ceux-ci
EP3381498A4 (fr) Microaiguille et procédé pour la produire
EP3320998A4 (fr) Procédé pour la fabrication d'unité de palier à roulement
EP3337864A4 (fr) Composition de revêtement pelable et procédé de fabrication de cette dernière
EP3713537A4 (fr) Compositions topiques, leur procédé de fabrication et leur procédé d'utilisation
EP3480258A4 (fr) Composition mao sous forme solide comprenant un al203, et procédé de fabrication de celle-ci
EP3373910A4 (fr) Formulation d'échinomycine, procédé de fabrication et méthode d'utilisation de cette dernière
EP2827851A4 (fr) Formulation à libération prolongée pour réduire la fréquence de la miction et procédé d'utilisation de celle-ci
EP3347446A4 (fr) Composition stable de blanchisserie ou de nettoyage, procédé pour la préparer, et procédé d'utilisation
EP3711741A4 (fr) Procédé de fabrication de complexe pour greffe osseuse et complexe pour greffe osseuse fabriqué selon le procédé
EP3778961A4 (fr) Rail, et procédé de fabrication de celui-ci
EP3517296A4 (fr) Film antiadhésif et procédé pour la fabrication de celui-ci

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20180424

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20190412

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/58 20060101ALI20190408BHEP

Ipc: A61K 9/50 20060101ALI20190408BHEP

Ipc: A61P 7/12 20060101ALI20190408BHEP

Ipc: A61P 7/00 20060101ALI20190408BHEP

Ipc: A61K 45/06 20060101ALI20190408BHEP

Ipc: A61K 31/19 20060101AFI20190408BHEP

Ipc: A61K 9/00 20060101ALI20190408BHEP

Ipc: A61K 31/167 20060101ALI20190408BHEP

Ipc: A61K 31/18 20060101ALI20190408BHEP

Ipc: A61K 31/192 20060101ALI20190408BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20191112